Version history
1 version on record. Newest first; the live version sits at the top with a live indicator.
- Live5/17/2026, 4:35:28 PM
083e6e96414aContent snapshot
{ "kind": "infographic", "prompt": "Synthesis: An Evidence Scorecard for Addiction Neuroscience figure 5", "provider": "other", "raw_fields": { "papers": [ { "n": 8, "doi": "10.1007/s11064-026-04743-5", "value": "39%", "metric": "AMPA/NMDA ratio or synaptic change magnitude", "cite_key": "Lagamjis2026", "text_access": "fulltext", "study_system": "rat", "value_source_sentence": "The MP + FLX group significantly decreased NMDA binding levels in the dorsal caudate-putamen (DCPU) (39%), ventral caudate-putamen (VCPU) (36%), and nucleus accumbens (Nac) (34%), compared to vehicle." }, { "n": 16, "doi": "10.1038/s41598-025-27577-7", "value": "p = 0.34", "metric": "AMPA/NMDA ratio or synaptic change magnitude", "cite_key": "Arezoomandan2025a", "text_access": "fulltext", "study_system": "rat", "value_source_sentence": "94, p = 0.34)." }, { "n": 2542, "doi": "10.1038/s41380-025-03351-z", "value": "95%", "metric": "AMPA/NMDA ratio or synaptic change magnitude", "cite_key": "DeSimone2026", "text_access": "fulltext", "study_system": "rat", "value_source_sentence": "Acute olanzapine increased PSD molecules levels in striatal regions, reducing Arc expression in frontal cortex (SMD [95%CIs]=-2." }, { "n": null, "doi": "10.1002/hipo.70062", "value": "3 NM", "metric": "AMPA/NMDA ratio or synaptic change magnitude", "cite_key": "Collingridge2026", "text_access": "fulltext", "study_system": "mouse", "value_source_sentence": "FIGURE 3 NMDAR‐LTP at SCC synapses (a more contemporary view)." }, { "n": null, "doi": "10.3390/biomedicines12112422", "value": "60. Pa", "metric": "AMPA/NMDA ratio or synaptic change magnitude", "cite_key": "ValladolidAcebes2024", "text_access": "fulltext", "study_system": "rat", "value_source_sentence": "60. Park H." }, { "n": 49, "doi": "10.1016/j.neurot.2026.e00839", "value": "reduced by approximately 50%", "metric": "AMPA/NMDA ratio or synaptic change magnitude", "cite_key": "Paul2026", "text_access": "fulltext", "study_system": "rat", "value_source_sentence": "In subsequent Phase 1 studies, doses and ratios of xanomeline and trospium were varied to optimize tolerability, and indeed, cholinergic AEs induced by xanomeline were reduced by approximately 50% when co-administered with trospium at the optimal ratios [ 101 ]." }, { "n": 12, "doi": "10.1073/pnas.2409325122", "value": "P = 0.0168", "metric": "AMPA/NMDA ratio or synaptic change magnitude", "cite_key": "Zucca2025", "text_access": "fulltext", "study_system": "mouse", "value_source_sentence": "Elfn1 P = 0.0168 unpaired t test; SYP P = 0." }, { "n": 5, "doi": "10.1038/s41531-025-01225-3", "value": "80%", "metric": "AMPA/NMDA ratio or synaptic change magnitude", "cite_key": "Marino2025", "text_access": "fulltext", "study_system": "rat", "value_source_sentence": "However, up to 80% of PD patients also experience cognitive and psychiatric issues." } ], "n_definition": "neurons recorded or animals per group", "scope_region": "VTA dopamine neurons", "comparison_id": "fig_sec3_vta_synaptic_plasticity", "source_cluster": 2, "comparison_type": "cross-study", "scope_population": "glutamatergic synapses onto DA neurons", "homogeneity_check": { "caveats": [ "Different drugs of abuse (cocaine, morphine, ethanol) with different mechanisms", "Mix of single-exposure and chronic exposure paradigms", "Variable time points post-drug (24h to weeks)", "Different electrophysiology recording conditions across labs" ], "comparable": true }, "suggested_plot_type": "forest_plot" }, "section_id": "section_12_evidence", "source_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewAddiction/blob/43d33061a22aa4fed3f7dc71fabbfa48ab1d6f48/evidence/section_12_evidence.json", "target_ref": "wiki_page:computationalreviewaddiction-12", "review_repo": "ComputationalReviewAddiction", "section_ref": "wiki_page:computationalreviewaddiction-12", "source_path": "evidence/section_12_evidence.json", "source_refs": [ "paper:paper-143727be2901", "paper:paper-3ac360ebf585", "paper:paper-4b08ec339dc5", "paper:paper-992c654f0031", "paper:paper-a0d22518f4cc", "paper:paper-a6ea2acae5d7", "paper:paper-da4f25ec9d05", "paper:paper-fd92110f9b26" ], "section_title": "Synthesis: An Evidence Scorecard for Addiction Neuroscience", "source_policy": { "mode": "public_source_pointer_with_short_context", "notes": [ "Local review repositories are read-only inputs.", "SciDEX stores paper metadata, structured evidence, file pointers, and short citation contexts; it does not copy full review prose." ], "source_commit_sha": "43d33061a22aa4fed3f7dc71fabbfa48ab1d6f48", "source_repository_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewAddiction" }, "generation_status": "complete", "review_bundle_ref": "analysis_bundle:ab-d95cfb705572", "origin_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewAddiction/blob/43d33061a22aa4fed3f7dc71fabbfa48ab1d6f48/evidence/section_12_evidence.json", "commit_sha": "43d33061a22aa4fed3f7dc71fabbfa48ab1d6f48", "created_by": "persona-jerome-lecoq-gbo-neuroscience", "repository_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewAddiction" }